Asthma/Steroid Withdrawal Study

计划入组 6 人 · 首次发布于 2006 年 11 月 2 日

Montelukast in Mild Asthmatic Children With Allergic Rhinitis (0476-367)

计划入组 191 人 · 首次发布于 2007 年 3 月 2 日

Inhaled Corticosteroid Withdrawal in Chronic Obstructive Pulmonary Disease (COPD)

计划入组 200 人 · 首次发布于 2020 年 7 月 2 日

PUR-0600

CHF-6162

Flunisolide

C₂₄H₃₁FO₆

TFF Pharmaceuticals

United States

Verona Pharma

United Kingdom

Aerovate Therapeutics, Inc.

United States

Large Real-World Study Confirms Long-Term Benefits of Allergen Immunotherapy in Pediatric Allergic Rhinitis

AstraZeneca's Breztri Shows Significant Improvement in Phase III Asthma Trials

GSK's Relvar Ellipta Demonstrates Superior Asthma Control in Landmark Real-World Study